What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide derived from a protein naturally found in human gastric juice . While its tissue-healing properties have been studied across many systems, the skin is one area where its mechanisms are particularly relevant. Skin is the body's largest organ and its primary barrier against the outside world, and maintaining its health and repair capacity is essential.

For a complete overview of BPC-157, see our BPC-157 benefits guide.

How Skin Heals

Understanding how BPC-157 may support skin health starts with understanding how skin repairs itself. Skin wound healing follows four overlapping phases:

1. Hemostasis (minutes): Blood clotting stops bleeding and forms a temporary wound matrix.
2. Inflammation (hours to days): Immune cells arrive to clear debris and fight potential infection. This phase involves redness, swelling, and warmth.
3. Proliferation (days to weeks): New blood vessels form (angiogenesis), fibroblasts produce collagen, and new skin tissue (granulation tissue) fills the wound. The wound contracts and new epithelial cells migrate across the surface.
4. Remodeling (weeks to months): Collagen is reorganized and cross-linked, strengthening the repair. Scar tissue matures and softens over time.

BPC-157 appears to positively influence multiple phases of this process, which is why it has attracted interest for skin health applications.

How BPC-157 Supports Skin Health

Promoting Angiogenesis

One of BPC-157's most well-documented effects is its ability to stimulate new blood vessel formation . In wound healing, angiogenesis is critical because new blood vessels deliver oxygen, nutrients, and growth factors to the repair site. Without adequate blood supply, wounds heal slowly and are more prone to complications.

In animal studies, BPC-157-treated wounds showed significantly greater blood vessel density compared to controls, which correlated with faster healing rates .

Increasing Collagen Production

Collagen is the primary structural protein in skin, making up roughly 75-80% of its dry weight. BPC-157 has been shown to increase collagen deposition at wound sites in animal models . More importantly, the collagen in BPC-157-treated wounds appeared to be better organized, resembling normal skin architecture rather than disorganized scar tissue.

This is significant because collagen quality and organization determine both the strength and appearance of healed skin. Better-organized collagen means stronger repairs and potentially less visible scarring.

Upregulating Growth Factors

BPC-157 increases the expression of several growth factors involved in skin repair:

• VEGF (Vascular Endothelial Growth Factor): Drives blood vessel formation
• EGF receptors (Epidermal Growth Factor receptors): Promote skin cell proliferation and migration
• Growth hormone receptors: Enhance tissue responsiveness to growth signals

Modulating Inflammation

The inflammatory phase of wound healing is necessary but must be properly controlled. Excessive inflammation delays healing and increases scarring. BPC-157 modulates the inflammatory response, helping wounds transition from the inflammatory phase to the proliferative (healing) phase more efficiently .

Nitric Oxide System Interaction

The nitric oxide system plays important roles in skin, including regulating blood flow, immune defense, and cell signaling during wound repair. BPC-157's modulation of this system appears to support optimal conditions for skin healing .

What the Animal Research Shows

Wound Healing

Multiple animal studies have examined BPC-157's effects on skin wound healing. Key findings include:

• Faster wound closure: BPC-157-treated wounds in rodent models closed significantly faster than untreated controls
• Improved tissue quality: Healed wounds showed better collagen organization and more complete epithelialization (skin surface coverage)
• Increased tensile strength: The healed skin was stronger and more resistant to reopening
• Reduced inflammation: Lower levels of pro-inflammatory markers at the wound site

Burn Healing

In rodent burn models, BPC-157 has shown the ability to accelerate healing of both superficial and deeper burns. Treated burns showed faster re-epithelialization, reduced inflammatory infiltrate, and improved tissue architecture compared to controls .

Burns are particularly challenging because they damage multiple skin layers and often result in significant scarring. The finding that BPC-157 improves the quality of burn healing, not just the speed, is noteworthy.

Skin Flap Survival

In surgical models involving skin flaps (sections of skin that are partially detached and repositioned), BPC-157 improved flap survival rates. This effect is attributed to its pro-angiogenic properties, as flap failure typically results from inadequate blood supply to the repositioned tissue .

Corticosteroid-Impaired Healing

Corticosteroid medications are known to impair wound healing by suppressing the inflammatory and proliferative phases. In animal studies, BPC-157 was able to counteract some of the negative effects of corticosteroids on wound healing . This is relevant for individuals who take corticosteroids and experience slow healing as a side effect.

Diabetic Wound Healing

Impaired wound healing is a significant complication of diabetes. While this area of BPC-157 research is limited, preliminary animal data suggests the peptide may support wound healing even in the context of metabolic impairment . This requires substantially more investigation before any conclusions can be drawn for human diabetic patients.

BPC-157 and Skin Aging

While BPC-157 has not been specifically studied as a cosmetic anti-aging compound, several of its mechanisms are directly relevant to skin aging:

• Collagen decline: Skin loses roughly 1% of its collagen per year after age 30 . BPC-157's ability to stimulate collagen production is potentially relevant to maintaining skin structure.
• Reduced blood supply: Aging skin receives less blood flow, which contributes to thinning, dryness, and slower healing. BPC-157's pro-angiogenic effects may help maintain skin perfusion.
• Chronic inflammation: Age-related inflammation in the skin contributes to breakdown of the extracellular matrix. BPC-157's anti-inflammatory properties may help protect against this process.
• Slower wound healing: Older adults heal more slowly. BPC-157's wound-healing effects could be particularly valuable in this context.

For more on BPC-157 and aging, see our BPC-157 for anti-aging guide.

We want to be clear: BPC-157 is not a wrinkle treatment or cosmetic product. Its skin-related benefits are primarily about tissue repair and healing function, not cosmetic appearance. Any cosmetic improvements would be secondary to improved skin health and repair capacity.

Administration for Skin Health

For skin-specific applications, both systemic and local approaches have been discussed:

Subcutaneous Injection Near the Target Area

For specific wound healing or skin repair, injecting subcutaneously near (but not into) the affected area delivers a localized dose. This may provide higher peptide concentrations at the target site. For injection guidance, see our BPC-157 how to inject guide.

Systemic Subcutaneous Injection

Abdominal subcutaneous injection delivers BPC-157 systemically, which may support overall skin health rather than targeting a specific wound. Animal studies have shown that systemic BPC-157 still produces wound-healing effects, suggesting it reaches the skin through circulation .

Oral Administration

Oral BPC-157 may also support skin health through systemic effects, though this route has been less studied specifically for skin applications compared to gut health. See our BPC-157 for gut health guide.

Topical Application

Some research has explored topical BPC-157 application directly to wounds. Early animal data suggests potential, but topical formulations are less commonly available and less studied than injectable forms . This remains an area of active investigation.

Dosing for Skin Health

Dosing for skin health follows the general BPC-157 protocols:

• Dose: 250 to 500 mcg per day, once or twice daily
• Route: Subcutaneous injection (near the wound for targeted healing, or abdominal for systemic effects)
• Cycle length: 4 to 8 weeks for most skin healing applications

Your physician will customize your protocol. For comprehensive dosing information, see our BPC-157 dosage guide.

What to Expect

Based on animal study timelines and anecdotal human reports:

• Week 1: Reduced redness and inflammation at wound or injury sites
• Weeks 2-3: Visible acceleration of wound closure. Improved appearance of healing tissue.
• Weeks 4-6: More complete healing. Better scar quality compared to expectations.
• Weeks 6-8: Continued remodeling and maturation of healed skin.

Individual results vary significantly. See our BPC-157 before and after guide for more on what to expect.

Safety and Side Effects

BPC-157 has demonstrated a clean safety profile in animal studies, with no identified toxic dose . Side effects are generally mild and may include injection site reactions, nausea, and occasional dizziness.

One consideration specific to skin applications: because BPC-157 promotes angiogenesis, individuals with skin conditions involving abnormal blood vessel growth should discuss this with their physician before using it.

For complete safety information, see our BPC-157 side effects guide.

How Form Blends Can Help

Whether you are dealing with a slow-healing wound, recovering from a skin procedure, or interested in supporting your skin's long-term health, Form Blends provides the physician guidance you need.

Our telehealth platform offers:

• A thorough evaluation of your skin health concerns and medical history
• Pharmaceutical-grade BPC-157 from licensed compounding pharmacies
• A personalized protocol targeting your specific skin health goals
• Guidance on optimal administration route for skin applications
• Ongoing physician monitoring throughout your treatment

Frequently Asked Questions

Can BPC-157 reduce wrinkles?

BPC-157 has not been studied as a cosmetic wrinkle treatment. Its effects on collagen production and skin repair may indirectly support skin quality, but it should not be thought of as a cosmetic anti-wrinkle therapy. Its primary skin-related value lies in wound healing and tissue repair.

Can I apply BPC-157 directly to a wound?

Topical application has been explored in early animal research and shows some promise. However, topical formulations are not widely available, and most clinical use involves subcutaneous injection. Do not apply injectable BPC-157 topically without your physician's guidance.

Will BPC-157 help with scarring?

Animal studies show that BPC-157-treated wounds produce better-organized collagen, which is associated with less conspicuous scarring. While this is encouraging, individual scar outcomes depend on many factors including genetics, wound location, and wound care. BPC-157 may improve scar quality but cannot guarantee scar-free healing.

Is BPC-157 safe for skin conditions like eczema or psoriasis?

BPC-157 has not been specifically studied for eczema, psoriasis, or other chronic inflammatory skin conditions. While its anti-inflammatory properties are relevant, these conditions involve complex immune dysfunction that may or may not respond to BPC-157. Discuss with both your dermatologist and prescribing physician before use.

How does BPC-157 compare to other wound healing treatments?

BPC-157 works through different mechanisms than conventional wound care products (such as growth factor gels or advanced wound dressings). It may be complementary to these approaches rather than a replacement. No head-to-head human studies exist comparing BPC-157 to standard wound healing therapies.